Papaioannou D, Geggie P, Klassen J
Clin Chim Acta. 1979 Nov 15;99(1):37-41. doi: 10.1016/0009-8981(79)90137-2.
Serum beta-2 microglobulin levels were measured in normal individuals and in breast cancer patients. It was observed that there was a significant rise in levels especially in advanced stages of the disease. It was concluded that patients with a beta-2 microglobulin/creatinine ratio of greater than 3.8 were likely to have metastatic breast cancer.
在正常个体和乳腺癌患者中测量了血清β-2微球蛋白水平。观察到该水平显著升高，尤其是在疾病的晚期阶段。得出的结论是，β-2微球蛋白/肌酐比值大于3.8的患者可能患有转移性乳腺癌。
